Patients with psoriatic arthritis (PsA) experience significant disease burden due to incomplete diagnostic evaluation and suboptimal use of effective therapies. In this case-based activity, Dr. Leonard Calabrese of the Cleveland Clinic addressing these practice gaps by sharing his recommendations for patient management at critical decision points in the diagnosis and treatment of patients with PsA. Dr. Calabrese also discusses the important role of shared decision-making over the course of the disease as a key strategy to individualize treatment and improve patient adherence. For each of the 3 cases, Dr. Calabrese provides a concise summary of key concepts to facilitate integration into clinical practice.
Course Credit:
0.75 AMA PRA Category 1 CreditTM
Dates:
Opens: 2021-01-22
Closes: 2022-01-22
Target Audience:
This activity is intended for a national audience of rheumatologists, dermatologists, primary care physicians, nurse practitioners, physician assistants, and other healthcare providers who manage patients with psoriatic arthritis.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
-
Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director, RJ Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, Ohio
Learning Objectives
- Utilize validated tools to assess Psoriatic Arthritis (PsA) disease burden and response to treatment
- Summarize the clinical pharmacology, including mechanism of action, as well as safety and efficacy, of evidence-based medications for PsA
- Utilize a treat-to-target approach with individualized evidence-based therapy to achieve disease remission/low disease activity and reduce symptom burden
- Individualize treatment of PsA based on treatment history and comorbidities
Faculty Disclosures
Leonard Calabrese, DO
Consultant: AbbVie, Amgen, BMS, Crescendo, Eli Lilly, Genentech, Gilead, GSK, Horizon, Jansen, Kiniksa, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, UCB
Speakers Bureau: AbbVie, BMS, Genentech, Novartis, Regeneron, Sanofi-Genzyme
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationship to disclose
Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
All members of the Eisenhower Health Education Committee have no relevant commercial relationships to disclose.